CanSino Biologics Inc (CJH) — Cash Flow Quality Index
CanSino Biologics Inc (CJH) has a Cash Flow Quality Index of -4.93x as of March 2022. Operating cash flow of €-598.15 Million is below net income of €121.41 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore CanSino Biologics Inc operating cash flow efficiency to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
CanSino Biologics Inc Cash Flow Quality Index (2021–2025)
Historical Cash Flow Quality Index for CanSino Biologics Inc across 2 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check CanSino Biologics Inc total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for CanSino Biologics Inc (2021–2025)
Year-by-year earnings quality comparison for CanSino Biologics Inc. For live market cap and the full company financial profile, see CJH stock market capitalisation.
| Year | Quality Index | Operating CF (EUR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 2.79x | €77.86 Million | €27.87 Million | ▲ +160.8% |
| 2021 | 1.07x | €2.05 Billion | €1.91 Billion | — |